Xiang Shu
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
-
- Metabolomics and Mass Spectrometry Studies 4
- RNA modifications and cancer 4
-
- Kidney Stones and Urolithiasis Treatments 4
- Lung Cancer Treatments and Mutations 4
- Renal cell carcinoma treatment 3
- Co-authors
- Wei Zheng (23 shared papers)Hui Cai (10 shared papers)Yong‐Bing Xiang (8 shared papers)Qiuyin Cai (11 shared papers)Gong Yang (6 shared papers)Xifeng Wu (10 shared papers)Xiao‐Ou Shu (10 shared papers)Wanghong Xu (2 shared papers)
- Journals
- American Journal of Epidemiology (6 papers)Carcinogenesis (4 papers)International Journal of Cancer (4 papers)Cancers (3 papers)British Journal of Cancer (3 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Xiang Shu
59 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 111
- Nephrology 142
- Cancer Research 154
- Complementary and Manual Therapy 19
- Oncology 205
- Pathology and Forensic Medicine 119
Countries citing papers authored by Xiang Shu
This map shows the geographic impact of Xiang Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Shu more than expected).
Fields of papers citing papers by Xiang Shu
This network shows the impact of papers produced by Xiang Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Shu. The network helps show where Xiang Shu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiang Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 149 | |
| 2 | 2019 | 109 | |
| 3 | 2008 | 67 | |
| 4 | 2011 | 61 | |
| 5 | 2009 | 44 | |
| 6 | 2014 | 43 | |
| 7 | 2017 | 41 | |
| 8 | 2018 | 38 | |
| 9 | 2018 | 36 | |
| 10 | 2018 | 35 | |
| 11 | 2013 | 34 | |
| 12 | 2015 | 34 | |
| 13 | 2019 | 33 | |
| 14 | 2022 | 32 | |
| 15 | 2010 | 32 | |
| 16 | 2016 | 32 | |
| 17 | 2021 | 31 | |
| 18 | 2018 | 28 | |
| 19 | 2013 | 26 | |
| 20 | 2019 | 25 |
About Xiang Shu
Xiang Shu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Genetics, Oncology and Public Health, Environmental and Occupational Health, having authored 65 papers that have together received 1.3k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (9 papers), Vector-borne infectious diseases (7 papers), Cancer Risks and Factors (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Kidney Stones and Urolithiasis Treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Nephrology (142 citations), Cancer Research (154 citations), Complementary and Manual Therapy (19 citations), Oncology (205 citations) and Pathology and Forensic Medicine (119 citations). Xiang Shu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Wei Zheng, Hui Cai, Yong‐Bing Xiang, Qiuyin Cai, Gong Yang, Xifeng Wu, Xiao‐Ou Shu, Wanghong Xu, Christina E. Bailey and Honglan Li. Their work appears in journals such as American Journal of Epidemiology, Carcinogenesis, International Journal of Cancer, Cancers and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.